More Cynata Therapeutics Limited news
Cynata Therapeutics LimitedASX: CYP

Cynata Receives NHS HRA Approval for Clinical Study

Dec 12, 2016 at 11:31 PM EST · Issued by Cynata Therapeutics Limited

Filed with ASX · Dec 12, 2016 at 11:31 PM EST

On 6ix: 6ix.com/news/cynata-receives-nhs-hra-approval-for-clinical-study

Cynata Therapeutics Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Cynata Therapeutics Limited on 6ix

Story so far

  • UK Regulatory Authority Approves Cynata GvHD Clinical TrialSep 19, 2016
  • Cynata Files Application to Commence Phase 1 Clinical TrialAug 1, 2016
  • Cynata Prepares for Phase 1 Clinical TrialJun 21, 2016

Earlier from Cynata Therapeutics

  • Cynata Files Further Patent ApplicationNov 28, 2016
  • Cynata Receives $1.749m R&D Tax Incentive RefundNov 15, 2016
  • Activities Report & Appendix 4COct 31, 2016
  • Efficacy for CYP MSC Technology in Preclinical Asthma StudyOct 16, 2016
  • UK Regulatory Authority Approves Cynata GvHD Clinical TrialSep 19, 2016

Later from Cynata Therapeutics

  • Cynatas Clinical Study Approved in AustrraliaDec 15, 2016
  • Cynata & FUJIFILM Sign Strategic Partnership AgreementJan 18, 2017
  • Cynata Successfully Completes Capital RaisingJan 22, 2017
  • Appendix 4C - quarterlyJan 25, 2017
  • Positive Preliminary Data from Preclinical HeartAttack StudyFeb 1, 2017
All Cynata Therapeutics news releases↗

Follow Cynata Therapeutics into a list and get an email when it puts out news.

Follow Cynata Therapeutics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer